ArticleCPT: pharmacometrics & systems pharmacology2026

Adaptive Dosing Trial Simulation Framework to Inform Dose Optimization: Case Study Using Longitudinal PKPD Models With PF-06804103 Phase 1 Data in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive and Low Solid Tumors.

Jerry Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.